Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus II Infection”

231 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 231 results

Testing effectiveness (Phase 2)UnknownNCT01529073
What this trial is testing

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Who this might be right for
HCV CoinfectionHIV Infection
Juan Macías 45
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Testing effectiveness (Phase 2)Study completedNCT00002423
What this trial is testing

Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Who this might be right for
HIV Infections
Glaxo Wellcome 100
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Testing effectiveness (Phase 2)Study completedNCT00145249
What this trial is testing

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

Who this might be right for
Cryptococcal Meningitis
National Institute of Allergy and Infectious Diseases (NIAID) 143
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableNot Yet RecruitingNCT07569913
What this trial is testing

Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

Who this might be right for
HIV1 InfectionHIV 2 InfectionSyphilis Infection+1 more
bioLytical Laboratories 500
Testing effectiveness (Phase 2)Study completedNCT02706717
What this trial is testing

Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 93
Early research (Phase 1)Study completedNCT00002313
What this trial is testing

Nystatin in HIV-Infected Patients

Who this might be right for
HIV Infections
Argus Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00001061
What this trial is testing

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 167
Testing effectiveness (Phase 2)Study completedNCT00002390
What this trial is testing

The Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00001057
What this trial is testing

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 105
Testing effectiveness (Phase 2)UnknownNCT02441231
What this trial is testing

Probiotic Visbiome for Inflammation and Translocation in HIV II

Who this might be right for
HIV-1 Infection
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Study completedNCT02038881
What this trial is testing

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Who this might be right for
Smallpox
Bavarian Nordic 87
Testing effectiveness (Phase 2)Study completedNCT01008813
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 306
Testing effectiveness (Phase 2)Study completedNCT00225303
What this trial is testing

TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI Use

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 116
Post-approval studies (Phase 4)Study completedNCT03290391
What this trial is testing

Linking Infectious and Narcology Care-Part II

Who this might be right for
HIV InfectionDrug Use
Boston Medical Center 225
Not applicableStudy completedNCT03146013
What this trial is testing

Dual Algorithm Post Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 100
Testing effectiveness (Phase 2)UnknownNCT04404049
What this trial is testing

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

Who this might be right for
HIV-1-infection
UBP Greater China (Shanghai) Co., Ltd 39
Next Page